Aker BioMarine AS announced that the company expects higher growth compared to the second quarter last year, but also expecting sales to be on par or higher than this quarter, the first quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64 NOK | 0.00% | -3.03% | +39.13% |
Feb. 14 | Aker BioMarine AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 14 | Aker BioMarine AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.13% | 520M | |
+2.98% | 3.02B | |
+5.10% | 1.74B | |
-6.28% | 1.26B | |
-10.48% | 1.24B | |
-1.30% | 1.24B | |
-.--% | 1.21B | |
0.00% | 1.21B | |
+8.27% | 1.17B | |
-2.93% | 1.12B |
- Stock
- Equities
- Stock Aker BioMarine - Oslo Bors
- News Aker BioMarine
- Aker BioMarine AS Provides Sales Guidance for the Second Quarter of 2023